T. Soh

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma

Dachuan Huang, C. Ong, A. Jeyasekharan, 2022, Science Translational Medicine.

Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma.

M. Ooi, W. Chng, B. Tai, 2018, Hematology/oncology and stem cell therapy.

Double Unit Umbilical Cord Blood Transplant for Adults with Acute Leukemia and Myelodysplastic Syndrome Results in Comparable Outcome As Matched Sibling or Unrelated Donor Transplant Only after Myeloablative Conditioning but Not Reduced Intensity Conditio

W. Hwang, H. Ng, L. Koh, 2014 .

Rapid production of clinical‐grade SARS‐CoV‐2 specific T cells

J. Low, W. Chng, J. Loh, 2020, Advances in cell and gene therapy.

Storage time affects umbilical cord blood viability

S. Watt, M. Guttridge, T. Soh, 2014, Transfusion.

Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus.

P. Law, L. Tan, Y. Linn, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Vinorelbine-Cyclophosphamide Compared to Cyclophosphamide in Peripheral Blood Stem Cell Mobilization for Multiple Myeloma

M. Ooi, W. Chng, Yunxin Chen, 2015 .

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY

J. Low, W. Chng, J. Loh, 2020, medRxiv.

Use of Peripherally Inserted Central Catheter (PICC) for the Infusion of Peripheral Blood Stem Cell Products Is Safe and Effective

W. Chng, L. Koh, E. Yap, 2020 .

A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection.

Y. Linn, M. Chan, T. Soh, 2024, Cytotherapy.